These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38828693)

  • 1. UBE2C as an Immune-Related Biomarker for Breast Cancer: A Study Based on Multiple Databases.
    Cui Y; Wang HZ; Song Y; Yang S; Sai FY; Yu DJ
    Chin Med Sci J; 2024 May; ():. PubMed ID: 38828693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer.
    Liu X; Wang W; Chen B; Wang S
    Aging (Albany NY); 2024 Apr; 16(8):7188-7216. PubMed ID: 38643462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis.
    Wang Y; Wang J; Tang Q; Ren G
    PLoS One; 2021; 16(2):e0247827. PubMed ID: 33630978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer.
    Yuan R; Zhang Y; Wang Y; Chen H; Zhang R; Hu Z; Chai C; Chen T
    Front Immunol; 2023; 14():1152678. PubMed ID: 37215111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Bioinformatics and Drug Sensitivity Analyses to Identify Molecular Characteristics Associated with Targeting Necroptosis in Breast Cancer and their Clinical Prognostic Significance.
    Zheng C; Guo H; Mo Y; Liu G
    Recent Pat Anticancer Drug Discov; 2024; 19(5):681-694. PubMed ID: 37653627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying
    Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
    PeerJ; 2023; 11():e16618. PubMed ID: 38099311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic genes for breast cancer related to systemic lupus erythematosus by integrated analysis and machine learning.
    Liang X; Peng Z; Lin Z; Lin X; Lin W; Deng Y; Yang S; Wei S
    Immunobiology; 2023 Sep; 228(5):152730. PubMed ID: 37582308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data.
    Mo CH; Gao L; Zhu XF; Wei KL; Zeng JJ; Chen G; Feng ZB
    Cancer Cell Int; 2017; 17():83. PubMed ID: 29021715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mining the potential prognostic value of synaptosomal-associated protein 25 (SNAP25) in colon cancer based on stromal-immune score.
    Zou J; Duan D; Yu C; Pan J; Xia J; Yang Z; Cai S
    PeerJ; 2020; 8():e10142. PubMed ID: 33150073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
    Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.
    Wu Z; Wan J; Wang J; Meng X; Qian H
    Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Weighted Gene Co-Expression Network Analysis to Identify Increased MND1 Expression as a Predictor of Poor Breast Cancer Survival.
    Bao Z; Cheng J; Zhu J; Ji S; Gu K; Zhao Y; Yu S; Meng Y
    Int J Gen Med; 2022; 15():4959-4974. PubMed ID: 35601002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis.
    Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X
    Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Breast Cancer Immune-related Prognostic Characteristics in Tumor Microenvironment.
    Tang Z; Li L; Huang X; Zhao Y; Liu Q; Zhang C
    Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38213151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
    Song C; Shang F; Tu W; Liu X
    BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE2 maybe serve as a prognostic biomarker in breast invasive carcinoma.
    Ling J; Peng N; Luo L
    J Clin Lab Anal; 2022 Jun; 36(6):e24362. PubMed ID: 35373393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a pyroptosis-related prognostic signature in breast cancer.
    Chen H; Luo H; Wang J; Li J; Jiang Y
    BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.